|
GB0920204D0
|
|
Combination preparations for the treatment of obesity and other related disorders in postmenopausal women
|
|
GB0920199D0
|
|
Exploitation of bmp-9 analogues as antihyper-glycaemic agents and appetite suppressants
|
|
GB0920200D0
|
|
Therapeutic vaccine for treatment of type 2-diabetes and impaired glucose tolerance
|
|
GB0920201D0
|
|
Exploitation of gene products expressed in intra-abdominal far cells as drugs targets for treatment of metabolic disorders associated with obesity
|
|
GB0920203D0
|
|
A process for identifying compounds capable of enhancing hepatic formulation of ketone bodies intended for clinical treatment of obesity
|
|
GB0920202D0
|
|
Method for the identification and characterisation of ghrelin acylating enzymes in gastric mucosa as drug targets
|
|
GB0906496D0
|
|
Method for inducing breast carcinoma stem cell death
|
|
GB0906484D0
|
|
Use of prostaganin for treatment of prostrate cancer
|
|
GB0906490D0
|
|
Use of tetanolic for treatment of breast cancer
|
|
DK512787D0
|
|
Sealing
|
